Overall rank by patents
#39,862
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 6 technology areas, active 2016–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR).
The verdict
Diacarta holds 6 US patents across 6 technology areas, rank #39,862 of 50,000 tracked assignees.
Diacarta Inc. has been granted 6 US utility patents between 2016 and 2023, placing Diacarta Inc. at rank #39,862 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 9.5 claims per patent with primary concentration in C12Q (MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICR). As a US Corporation, Diacarta Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Diacarta sits between Desvac (6 patents, rank #39,858) and Dicar Inc. (6 patents, rank #39,866) - the closest US assignees by grant volume. The composite Innovation Score of 27.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 3 in the 2015–2019 window, a +0% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Diacarta Inc.'s 9.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Diacarta Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Desvac
6 patents
Detec Systems LLC
6 patents
Develco Pharma Schweiz AG
6 patents
Devil Dog Concepts, LLC
6 patents
DiaMed GmbH
6 patents
Diadem S.r.l.
6 patents
Diamond Mattress Company, Inc.
6 patents
Dicar Inc.
6 patents
DiaCarta Inc.
6 patents
What this shows Diacarta holds 6 patents at rank #39,862, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #39,862 in granted patent volume.
Other assignees with the most granted patents in Diacarta's primary technology class.
Diacarta's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
28 Top 75% higher than 25% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 1 | 16.7% |
| 2017 | 1 | 16.7% |
| 2019 | 1 | 16.7% |
| 2021 | 1 | 16.7% |
| 2022 | 1 | 16.7% |
| 2023 | 1 | 16.7% |
Top 6 of 6 technology areas
Overall rank by patents
#39,862
Across all tracked assignees
27.8 out of 100
How to use this portfolio
Diacarta's 6 grants land it in the top 75% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.